Aurobindo Pharma reported 21.22 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Cipla 35.82 12.26 Jun/2026
Divis Laboratories Ltd 58.35 1.4 Jun/2026
Dr.Reddys Laboratories 33.14 9.42 Jun/2026
Hindustan Unilever 46.13 4.04 Jun/2026
Sun Pharmaceuticals 38.39 0.23 Jun/2026
UPL 24.05 2.23 Jun/2026